| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |